Erratum: Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells (Cell Reports (2016) 15(5) (1024–1036) (S2211124716303965) (10.1016/j.celrep.2016.03.090));Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells

Cell Reports

Volumn 15, Issue 5, 2016, Pages 1024-1036

  Topol, Aaron ^a   Zhu, Shijia ^a   Hartley, Brigham J ^a   English, Jane ^b   Hauberg, Mads E ^c   Tran, Ngoc ^a   Rittenhouse, Chelsea Ann ^a   Simone, Anthony ^d   Ruderfer, Douglas M ^a   Johnson, Jessica ^a   Readhead, Ben ^a   Hadas, Yoav ^a   Gochman, Peter A ^f   Wang, Ying Chih ^a   Shah, Hardik ^a   Cagney, Gerard ^e   Rapoport, Judith ^f   Gage, Fred H ^d   Dudley, Joel T ^a   Sklar, Pamela ^a   Mattheisen, Manuel ^c   Cotter, David ^b   Fang, Gang ^a   Brennand, Kristen J ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BEAUMONT HOSPITAL   (Ireland)

^c AARHUS UNIVERSITY   (Denmark)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Human induced pluripotent stem cell; MicroRNA 9; Neural progenitor cells; Schizophrenia

Indexed keywords

MICRORNA 9; MICRORNA; MIRN92 MICRORNA, HUMAN; PROTEOME; TRANSCRIPTION FACTOR;

ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NEURAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEOMICS; RNA SEQUENCE; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; BIOLOGICAL MODEL; CASE CONTROL STUDY; CELL MOTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MOLECULAR GENETICS; NERVE CELL; PATHOLOGY;

CASE-CONTROL STUDIES; CELL MOVEMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICRORNAS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE ANNOTATION; NEURAL STEM CELLS; NEURONS; PROTEOME; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 84963954999     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.08.073     Document Type: Erratum

References (40)

1. Balwierz P.J., Pachkov M., Arnold P., Gruber A.J., Zavolan M., van Nimwegen E. ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs. Genome Res. 2014, 24:869-884.
2. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
3. Brennand K., Savas J.N., Kim Y., Tran N., Simone A., Hashimoto-Torii K., Beaumont K.G., Kim H.J., Topol A., Ladran I., et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 2015, 20:361-368.
4. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
5. Collins A.L., Kim Y., Bloom R.J., Kelada S.N., Sethupathy P., Sullivan P.F. Transcriptional targets of the schizophrenia risk gene MIR137. Transl. Psychiatry 2014, 4:e404.
6. Conlon E.M., Liu X.S., Lieb J.D., Liu J.S. Integrating regulatory motif discovery and genome-wide expression analysis. Proc. Natl. Acad. Sci. USA 2003, 100:3339-3344.
7. De Bosscher K., Haegeman G., Elewaut D. Targeting inflammation using selective glucocorticoid receptor modulators. Curr. Opin. Pharmacol. 2010, 10:497-504.
8. Delaloy C., Liu L., Lee J.A., Su H., Shen F., Yang G.Y., Young W.L., Ivey K.N., Gao F.B. MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell 2010, 6:323-335.
9. Friedman R.C., Farh K.K.-H., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
10. Gulsuner S., Walsh T., Watts A.C., Lee M.K., Thornton A.M., Casadei S., Rippey C., Shahin H., Nimgaonkar V.L., Go R.C., et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013, 154:518-529. Consortium on the Genetics of Schizophrenia (COGS), PAARTNERS Study GroupPAARTNERS Study Group.
11. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
12. Hauberg M.E., Roussos P., Grove J., Borglum A.D., Mattheisen M. Analyzing the role of microRNAs in schizophrenia in the context of common genetic risk variants. JAMA Psychiatry 2016, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Published online March 9, 2016. 10.1001/jamapsychiatry.2015.3018.
13. Jarskog L.F., Miyamoto S., Lieberman J.A. Schizophrenia: new pathological insights and therapies. Annu. Rev. Med. 2007, 58:49-61.
14. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 2010, 11:402-416.
15. Lee I.S., Carvalho C.M.B., Douvaras P., Ho S.M., Hartley B.J., Zuccherato L.W., Ladran I.G., Siegel A.J., McCarthy S., Malhotra D., et al. Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells. NPJ Schizophr 2015, 1:15019.
16. Lin G.N., Corominas R., Lemmens I., Yang X., Tavernier J., Hill D.E., Vidal M., Sebat J., Iakoucheva L.M. Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases. Neuron 2015, 85:742-754.
17. Matys V., Fricke E., Geffers R., Gössling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003, 31:374-378.
18. Meza-Sosa K.F., Pedraza-Alva G., Pérez-Martínez L. microRNAs: key triggers of neuronal cell fate. Front. Cell. Neurosci. 2014, 8:175.
19. Miller B.H., Zeier Z., Xi L., Lanz T.A., Deng S., Strathmann J., Willoughby D., Kenny P.J., Elsworth J.D., Lawrence M.S., et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc. Natl. Acad. Sci. USA 2012, 109:3125-3130.
20. Miller J.A., Ding S.L., Sunkin S.M., Smith K.A., Ng L., Szafer A., Ebbert A., Riley Z.L., Royall J.J., Aiona K., et al. Transcriptional landscape of the prenatal human brain. Nature 2014, 508:199-206.
21. Perkins D.O., Jeffries C.D., Jarskog L.F., Thomson J.M., Woods K., Newman M.A., Parker J.S., Jin J., Hammond S.M. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007, 8:R27.
22. Rapoport J.L., Giedd J.N., Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 2012, 17:1228-1238.
23. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., et al. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium.
24. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159. Multicenter Genetic Studies of Schizophrenia Consortium, Psychosis Endophenotypes International ConsortiumPsychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2.
25. Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140.
26. Sandelin A., Alkema W., Engström P., Wasserman W.W., Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004, 32:D91-D94.
27. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427. Schizophrenia Working Group of the Psychiatric Genomics Consortium.
28. Setty M., Helmy K., Khan A.A., Silber J., Arvey A., Neezen F., Agius P., Huse J.T., Holland E.C., Leslie C.S. Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma. Mol. Syst. Biol. 2012, 8:605.
29. Shibata M., Nakao H., Kiyonari H., Abe T., Aizawa S. MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J. Neurosci. 2011, 31:3407-3422.
30. Smrt R.D., Szulwach K.E., Pfeiffer R.L., Li X., Guo W., Pathania M., Teng Z.Q., Luo Y., Peng J., Bordey A., et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 2010, 28:1060-1070.
31. Sun G., Ye P., Murai K., Lang M.F., Li S., Zhang H., Li W., Fu C., Yin J., Wang A., et al. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells. Nat. Commun. 2011, 2:529.
32. Topol A., Tran N.N., Brennand K.J. A guide to generating and using hiPSC derived NPCs for the study of neurological diseases. J. Vis. Exp. 2015, 96:e52495.
33. Topol A., Zhu S., Tran N., Simone A., Fang G., Brennand K.J. Altered WNT signaling in human induced pluripotent stem cell neural progenitor cells derived from four schizophrenia patients. Biol. Psychiatry 2015, 78:e29-e34.
34. Waggott D., Chu K., Yin S., Wouters B.G., Liu F.F., Boutros P.C. NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics 2012, 28:1546-1548.
35. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
36. Wong A.H., Van Tol H.H. Schizophrenia: from phenomenology to neurobiology. Neurosci. Biobehav. Rev. 2003, 27:269-306.
37. Yang J.H., Li J.H., Shao P., Zhou H., Chen Y.Q., Qu L.H. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2011, 39:D202-D209.
38. Yu D.X., Di Giorgio F.P., Yao J., Marchetto M.C., Brennand K., Wright R., Mei A., McHenry L., Lisuk D., Grasmick J.M., et al. Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Reports 2014, 2:295-310.
39. Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005, 4:e17.
40. Zhao C., Sun G., Li S., Shi Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 2009, 16:365-371.